{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:34:48Z","timestamp":1792002888596,"version":"4.4.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,1,20]],"date-time":"2011-01-20T00:00:00Z","timestamp":1295481600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1136\/ard.2010.139360","type":"journal-article","created":{"date-parts":[[2011,1,21]],"date-time":"2011-01-21T20:25:20Z","timestamp":1295641520000},"page":"571-575","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":206,"title":["EULAR recommendations for calcium pyrophosphate deposition. Part II: Management"],"prefix":"10.1016","volume":"70","author":[{"given":"W","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Doherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Barskova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P-A","family":"Guerne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T L","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B F","family":"Leeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Perez-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Pimentao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Punzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Richette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Sivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Uhlig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Watt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Bardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2010.139360_bib1","article-title":"EULAR recommendations for calcium pyrophosphate crystal associated arthritis. Part I: Terminology and diagnosis.","author":"Zhang","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.139360_bib2","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/ard.2006.055269","article-title":"EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).","volume":"65","author":"Zhang","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.139360_bib3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.joca.2007.12.013","article-title":"OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines.","volume":"16","author":"Zhang","year":"2008","journal-title":"Osteoarthr Cartil"},{"key":"10.1136\/ard.2010.139360_bib4","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1136\/ard.2004.023697","article-title":"EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees.","volume":"63","author":"Dougados","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.139360_bib5","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1136\/bmj.318.7183.593","article-title":"Clinical guidelines: developing guidelines.","volume":"318","author":"Shekelle","year":"1999","journal-title":"BMJ"},{"key":"10.1136\/ard.2010.139360_bib6","series-title":"Statistical Power Analysis for the Behavioral Sciences.","author":"Cohen","year":"1988"},{"key":"10.1136\/ard.2010.139360_bib7","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/bmj.310.6977.452","article-title":"The number needed to treat: a clinically useful measure of treatment effect.","volume":"310","author":"Cook","year":"1995","journal-title":"BMJ"},{"key":"10.1136\/ard.2010.139360_bib8","series-title":"Epidemiologic Research \u2013 Principles and Quantitative Methods.","author":"Kleinbaum","year":"1982"},{"key":"10.1136\/ard.2010.139360_bib9","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1136\/ard.2004.028886","article-title":"EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).","volume":"64","author":"Zhang","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.139360_bib10","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1365-2753.2006.00629.x","article-title":"Evidence-based clinical guidelines: a new system to better determine true strength of recommendation.","volume":"12","author":"Roddy","year":"2006","journal-title":"J Eval Clin Pract"},{"key":"10.1136\/ard.2010.139360_bib11","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0140-6736(81)91488-4","article-title":"Effect of intra-articular yttrium-90 on chronic pyrophosphate arthropathy of the knee.","volume":"2","author":"Doherty","year":"1981","journal-title":"Lancet"},{"key":"10.1136\/ard.2010.139360_bib12","first-page":"327","article-title":"Prospective 6-month, double-blind trial of hydroxychloroquine treatment of CPDD.","volume":"23","author":"Rothschild","year":"1997","journal-title":"Compr Ther"},{"key":"10.1136\/ard.2010.139360_bib13","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1053\/joca.2002.0516","article-title":"A randomized controlled trial to evaluate the slow-acting symptom modifying effects of a regimen containing colchicine in a subset of patients with osteoarthritis of the knee.","volume":"10","author":"Das","year":"2002","journal-title":"Osteoarthr Cartil"},{"key":"10.1136\/ard.2010.139360_bib14","first-page":"487","article-title":"Intravenous colchicine use in crystal-induced arthropathies: a retrospective analysis of hospitalized patients.","volume":"15","author":"Maldonado","year":"1997","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.2010.139360_bib15","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/art.1780220421","article-title":"Colchicine and pseudogout.","volume":"22","author":"Spilberg","year":"1979","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.139360_bib16","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/art.1780230320","article-title":"Intravenous colchicine in the treatment of acute pseudogout.","volume":"23","author":"Tabatabai","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.139360_bib17","first-page":"696","article-title":"ACTH revisited: effective treatment for acute crystal induced synovitis in patients with multiple medical problems.","volume":"21","author":"Ritter","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2010.139360_bib18","first-page":"248","article-title":"Corticosteroid therapy for the treatment of acute attacks of crystal-induced arthritis: an effective alternative to nonsteroidal antiinflammatory drugs.","volume":"63","author":"Werlen","year":"1996","journal-title":"Rev Rhum Engl Ed"},{"key":"10.1136\/ard.2010.139360_bib19","first-page":"1168","article-title":"Prospective use of intramuscular triamcinolone acetonide in pseudogout.","volume":"24","author":"Roane","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2010.139360_bib20","first-page":"804","article-title":"Colchicine prophylaxis in pseudogout.","volume":"13","author":"Alvarellos","year":"1986","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2010.139360_bib21","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/art.22389","article-title":"Methotrexate as an alternative therapy for chronic calcium pyrophosphate deposition disease: an exploratory analysis.","volume":"56","author":"Chollet-Janin","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.139360_bib22","first-page":"539","article-title":"Probenecid therapy of refractory CPPD deposition disease.","volume":"42","author":"Trostle","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.139360_bib23","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1136\/ard.42.Suppl_1.106","article-title":"Double blind, placebo controlled trial of magnesium carbonate in chronic pyrophosphate arthropathy.","volume":"42","author":"Doherty","year":"1983","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.139360_bib24","first-page":"1241","article-title":"The prevalence of chondrocalcinosis in the elderly and its association with knee osteoarthritis: the Framingham Study.","volume":"16","author":"Felson","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2010.139360_bib25","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/ard.62.6.513","article-title":"UK community prevalence of knee chondrocalcinosis: evidence that correlation with osteoarthritis is through a shared association with osteophyte.","volume":"62","author":"Neame","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.139360_bib26","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.joca.2007.06.014","article-title":"OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence.","volume":"15","author":"Zhang","year":"2007","journal-title":"Osteoarthr Cartil"},{"key":"10.1136\/ard.2010.139360_bib27","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ard.2008.104406","article-title":"EULAR\/EFORT Recommendations for the diagnosis and initial management of patients with acute or recent onset swelling of the knee.","volume":"69","author":"Landewe","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.139360_bib28","first-page":"331","article-title":"Local ice therapy during bouts of acute gouty arthritis.","volume":"29","author":"Schlesinger","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2010.139360_bib29","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/01.rhu.0000249864.95389.cf","article-title":"Response to application of ice may help differentiate between gouty arthritis and other inflammatory arthritides.","volume":"12","author":"Schlesinger","year":"2006","journal-title":"J Clin Rheumatol"},{"key":"10.1136\/ard.2010.139360_bib30","first-page":"283","article-title":"Joint and soft tissue injection.","volume":"66","author":"Cardone","year":"2002","journal-title":"Am Fam Physician"},{"key":"10.1136\/ard.2010.139360_bib31","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1445-5994.1987.tb01232.x","article-title":"Does colchicine work? The results of the first controlled study in acute gout.","volume":"17","author":"Ahern","year":"1987","journal-title":"Aust N Z J Med"},{"key":"10.1136\/ard.2010.139360_bib32","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.joca.2010.01.013","article-title":"OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009.","volume":"18","author":"Zhang","year":"2010","journal-title":"Osteoarthr Cartil"},{"key":"10.1136\/ard.2010.139360_bib33","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/ard.2003.011742","article-title":"EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT).","volume":"62","author":"Jordan","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.139360_bib34","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/ard.2006.062091","article-title":"EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).","volume":"66","author":"Zhang","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.139360_bib35","series-title":"Osteoarthritis: National Clinical Guideline for Care and Management in Adults.","author":"National Collaborating Centre for Chronic Conditions","year":"2008"},{"key":"10.1136\/ard.2010.139360_bib36","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/rheumatology\/32.3.189","article-title":"Pyrophosphate arthropathy: a prospective study.","volume":"32","author":"Doherty","year":"1993","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.2010.139360_bib37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/ard.54.1.53","article-title":"Factors affecting radiographic progression of knee osteoarthritis.","volume":"54","author":"Ledingham","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.139360_bib38","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/art.23103","article-title":"Hylan versus hyaluronic acid for osteoarthritis of the knee: a systematic review and meta-analysis.","volume":"57","author":"Reichenbach","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.139360_bib39","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1136\/ard.2009.109355","article-title":"Hyperalgesia, synovitis and multiple biomarkers of inflammation are suppressed by interleukin 1 inhibition in a novel animal model of gouty arthritis.","volume":"68","author":"Torres","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.139360_bib40","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1136\/ard.2009.108936","article-title":"The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study.","volume":"68","author":"Terkeltaub","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.139360_bib41","first-page":"506","article-title":"Acute pseudogout following parathyroidectomy.","volume":"54","author":"White","year":"1988","journal-title":"Am Surg"},{"key":"10.1136\/ard.2010.139360_bib42","first-page":"1036","article-title":"Pseudogout as a clue and complication in primary hyperparathyroidism.","volume":"106","author":"Geelhoed","year":"1989","journal-title":"Surgery"},{"key":"10.1136\/ard.2010.139360_bib43","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1053\/jhep.2001.24783","article-title":"Diagnosis and management of hemochromatosis.","volume":"33","author":"Tavill","year":"2001","journal-title":"Hepatology"},{"key":"10.1136\/ard.2010.139360_bib44","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4158\/EP.11.1.49","article-title":"The American Association of Clinical Endocrinologists and the American Association of Endocrine Surgeons position statement on the diagnosis and management of primary hyperparathyroidism.","volume":"11","author":"AACE\/AAES Task Force on Primary Hyperparathyroidism","year":"2005","journal-title":"Endocrine Practice"},{"key":"10.1136\/ard.2010.139360_bib45","first-page":"772","article-title":"The effect of calcium and magnesium ions on calcium pyrophosphate crystal formation in aqueous solutions.","volume":"8","author":"Cheng","year":"1981","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2010.139360_bib46","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/art.1780190116","article-title":"Crystal shedding and acute pseudogout. An hypothesis based on a therapeutic failure.","volume":"19","author":"Bennett","year":"1976","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.139360_bib47","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/0002-9343(75)90481-7","article-title":"Hypomagnesemia due to renal disease of unknown etiology.","volume":"59","author":"Runeberg","year":"1975","journal-title":"Am J Med"},{"key":"10.1136\/ard.2010.139360_bib48","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1126\/science.289.5477.265","article-title":"Role of the mouse ank gene in control of tissue calcification and arthritis.","volume":"289","author":"Ho","year":"2000","journal-title":"Science"},{"key":"10.1136\/ard.2010.139360_bib49","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1136\/ard.60.10.962","article-title":"Dissolution of calcium pyrophosphate crystals by polyphosphates: an in vitro and ex vivo study.","volume":"60","author":"Cini","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.139360_bib50","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0166-1280(98)00298-X","article-title":"Molecular modeling of inhibition of crystals of calcium pyrophosphate dihydrate by phosphocitrate.","volume":"454","author":"Wierzbicki","year":"1998","journal-title":"J Mol Struct (Theochem)"},{"key":"10.1136\/ard.2010.139360_bib51","first-page":"819","article-title":"Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study. I. The MAPPING study.","volume":"23","author":"Salaffi","year":"2005","journal-title":"Clin Exp Rheumatol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724146043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724146043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2010.139360","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:03:04Z","timestamp":1779249784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724146043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0003496724146043"],"URL":"https:\/\/doi.org\/10.1136\/ard.2010.139360","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EULAR recommendations for calcium pyrophosphate deposition. Part II: Management","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2010.139360","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1136\/ard.2010.139105","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}